Filter
786
Filtered Results: 786
Text search:
serologic
surveillance
Featured
Recommendations
91
New Publications
222
Language
Document type
No document type
412
Guidelines
172
Studies & Reports
96
Manuals
37
Strategic & Response Plan
27
Fact sheets
26
Situation Updates
9
Infographics
4
Training Material
2
Resource Platforms
1
Countries / Regions
India
39
Global
31
Latin America and the Carribbean
21
Africa
20
Nigeria
19
Congo, Democratic Republic of
16
Ethiopia
16
Philippines
15
South Africa
15
Bangladesh
14
Brazil
13
Western and Central Europe
11
Nepal
10
Sierra Leone
10
Tanzania
10
Senegal
9
Zambia
9
West and Central Africa
8
East and Southern Africa
8
Kenya
7
Uganda
7
Rwanda
6
Burkina Faso
6
Germany
6
Russia
6
Central African Republic
6
Haiti
5
Asia
5
Venezuela
5
Eastern Europe
5
Angola
5
Colombia
4
Cameroon
4
Syria
4
Malawi
4
Mozambique
4
Middle East and North Africa
4
Namibia
4
Liberia
4
Madagascar
4
Ukraine
3
Lesotho
3
Ghana
3
Benin
3
Afghanistan
3
USA
3
South–East Asia Region
3
Pakistan
3
North Macedonia
2
Iran
2
Guinea
2
Cambodia
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Paraguay
2
France
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Lebanon
2
Sudan
2
Chad
2
Botswana
2
South Sudan
2
Iraq
2
Tajikistan
1
Mexico
1
Turkey
1
Australia
1
Togo
1
China
1
Albania
1
Laos
1
Peru
1
Zimbabwe
1
Morocco
1
Qatar
1
Italy
1
Western Pacific Region
1
Tunisia
1
Portugal
1
Southern Africa
1
Argentina
1
Vietnam
1
Sri Lanka
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Libya
1
Bhutan
1
Indonesia
1
Somalia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
276
Clinical Guidelines
131
Pharmacy & Technologies
38
Public Health
23
Key Resources
15
Women & Child Health
12
Capacity Building
3
Toolboxes
COVID-19
111
Rapid Response
92
NTDs
90
HIV
89
Zika
36
TB
28
Ebola
28
AMR
13
Refugee
10
Planetary Health
10
Pharmacy
9
Polio
8
Cholera
6
Mental Health
5
Natural Hazards
4
Caregiver
4
Disability
1
NCDs
1
Conflict
1
Global Health Education
1
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
first issued 18 August 2022
Guía Nacional para el Manejo de la Enfermedad por el Virus de la Chikungunya
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
